Lannett Company Receives Approval for Baclofen Tablets.PHILADELPHIA -- Lannett Company, Inc. (AMEX AMEX See: American Stock Exchange :LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) for its Abbreviated New Drug Application abbreviated new drug application Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar (ANDA ANDA abbr. abbreviated new drug application ) for Baclofen 20mg tablets. According to NDC Health, total annual sales of Baclofen in 2004 were $89.5 million. Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus clonus /clo·nus/ (klo´nus) 1. alternate involuntary muscular contraction and relaxation in rapid succession. 2. , and muscular rigidity. The approval brings to nine the total Lannett ANDA's approved by the FDA in the last seven months. "We are grateful to our employees for their hard work and dedication in bringing about these results," said Arthur Bedrosian, president of Lannett. "We have been very active this year in expanding our product offerings and will look to maintain this momentum in the coming year." About Lannett Company: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company's website at www.lannett.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion